Utama › Dermatitis Atopik (Eksim) › New York › New York City
Kajian klinikal Dermatitis Atopik (Eksim) di New York City, NY
13 kajian untuk Dermatitis Atopik (Eksim) sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- OptiSkin Medical, New York
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Enveda Investigative Site, New York
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Mengambil pesertaFasa 2
- Investigational Site, New York
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Mengambil peserta
- Weill Cornell Medicine, New York
- Columbia University Irving Medical Center, New York
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Sadick Research Group, LLC, New York
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Inmagene Site 21, New York
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Mengambil pesertaFasa 3
- Equity Medical /ID# 265814, New York
- Weill Cornell Medicine /ID# 265793, New York
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Mengambil pesertaFasa 1
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Mengambil pesertaFasa 2
- Private Practice - Dr. Bobby Buka, New York
- Icahn School of Medicine at Mount Sinai, New York
- Sadick Research Group, New York
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Mengambil pesertaKajian pemerhatian
- Galderma Investigational Site - 7051, New York
- Galderma Investigational Site 7109, New York
- Galderma Investigational Site 8279, New York
Allergy and Immunology Natural History Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Mengambil pesertaFasa 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Pfizer, New York
Kajian Dermatitis Atopik (Eksim) di bandar lain
- Los Angeles, CA11 kajian
- Washington, DC11 kajian
- San Antonio, TX10 kajian
- San Diego, CA10 kajian
- Birmingham, AL9 kajian
- Miami, FL9 kajian
- Dallas, TX8 kajian
- Huntington Beach, CA8 kajian
- Sacramento, CA8 kajian
- Troy, MI8 kajian
- Indianapolis, IN7 kajian
- Pittsburgh, PA7 kajian
Kajian lain di New York City
- Kanser Payudara136 kajian
- Kanser Paru-paru Bukan Sel Kecil121 kajian
- Kanser (semua jenis)109 kajian
- Kanser Prostat103 kajian
- Kanser Metastatik93 kajian
- Kanser Kolorektal78 kajian
- Kanser Ovari69 kajian
- Kanser Paru-paru60 kajian
- Mieloma Pelbagai60 kajian
- Kanser Pankreas60 kajian
- Kanser Endometrium52 kajian
- Leukemia Mieloid Akut51 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.